Hematopoietic stem cells are a critical sub-population of whole bone marrow in the treatment of myocardial infarction

Journals Menu

Follow SCIRP

ISSN Print: 2161-6760
ISSN Online: 2161-6787
www.scirp.org/journal/scd
E-mail: scd@scirp.org

"Hematopoietic stem cells are a critical sub-population of whole bone marrow in the treatment of myocardial infarction"
written by Philip Davy, Brienne Walker, Livingston Wong, Richard Allsopp,
published by Stem Cell Discovery, Vol.3 No.2, 2013

has been cited by the following article(s):

[1]	Comparing stemness gene expression between stem cell subpopulations from peripheral blood and adipose tissue
	American Journal of Stem Cells, 2018

[2]	Mechanistic effects of mesenchymal and hematopoietic stem cells: New therapeutic targets in myocardial infarction
	Journal of Cellular Biochemistry, 2018

[3]	Human adipose stem cell and ASC-derived cardiac progenitor cellular therapy improves outcomes in a murine model of myocardial infarction
	2015

[4]	Stem Cells and Cloning: Advances and Applications 2015: 8 135–148
	Stem cells and cloning: advances and applications, 2015

[5]	Human adipose stem cell and ASC-derived cardiac progenitor cellular therapy improves outcomes in a murine model of myocardial infarction.
	Stem Cells and Cloning: Advances and Applications, 2014

[6]	Theraputic Effect of Human Stem Cell Treatment on Cardiac Function and Myocardia Perfusion
	University of Hawaii at Manoa, 2014

[7]	Engraftment of pre-differentiated stem cells into cardiomyocytes in an animal model of ischemic cardiopathy
	Stem Cell Discovery, 2013

Follow SCIRP